Fonte: Biomedicine & Pharmacotherapy. Unidades: FM, ICB
Assuntos: NEOPLASIAS PULMONARES (TERAPIA), APOPTOSE, FÁRMACOS (SISTEMA RESPIRATÓRIO), ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Sarah Fernandes et al. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells. Biomedicine & Pharmacotherapy, v. 68, n. 8, p. 1015-1022, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2014.09.007. Acesso em: 02 nov. 2024.APA
Teixeira, S. F., Azevedo, R. A. de, Salomon, M. A. C., Jorge, S. D., Levy, D., Bydlowski, S. P., et al. (2014). Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells. Biomedicine & Pharmacotherapy, 68( 8), 1015-1022. doi:10.1016/j.biopha.2014.09.007NLM
Teixeira SF, Azevedo RA de, Salomon MAC, Jorge SD, Levy D, Bydlowski SP, Rodrigues CP, Pizzo CR, Barbuto JAM, Ferreira AK. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2014 ; 68( 8): 1015-1022.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.biopha.2014.09.007Vancouver
Teixeira SF, Azevedo RA de, Salomon MAC, Jorge SD, Levy D, Bydlowski SP, Rodrigues CP, Pizzo CR, Barbuto JAM, Ferreira AK. Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2014 ; 68( 8): 1015-1022.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.biopha.2014.09.007